{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:58:04Z","timestamp":1767902284760,"version":"3.49.0"},"reference-count":15,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2019,10,7]]},"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1136\/ejhpharm-2019-002048","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T17:15:47Z","timestamp":1571246147000},"page":"112-114","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis"],"prefix":"10.1136","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-5671","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Rodr\u00edguez de Castro","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Cabue\u00f1es, Gij\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6919-7938","authenticated-orcid":false,"given":"Cristina Martinez-M\u00fagica","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Cabue\u00f1es, Gij\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aitor","family":"Ayastuy Ruiz","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Cabue\u00f1es, Gij\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Fern\u00e1ndez Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Cabue\u00f1es, Gij\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"2025090704201759000_28.2.112.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483"},{"key":"2025090704201759000_28.2.112.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30481-1"},{"key":"2025090704201759000_28.2.112.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2025090704201759000_28.2.112.4","unstructured":"EMA: European Medicines Agency . Ficha t\u00e9cnica Tysabry. Available: https:\/\/www.ema.europa.eu\/documents\/product-information\/tysabri-epar-product-information_es.pdf [Accessed 03 Feb 2019]."},{"key":"2025090704201759000_28.2.112.5","unstructured":"Olek MJ . Natalizumab for relapsing-remitting multiple sclerosis in adults. [monograf\u00eda en Internet], 2019. Available: http:\/\/www.uptodate.com\/ [Accessed 22 Feb 2019]."},{"key":"2025090704201759000_28.2.112.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70040-5"},{"key":"2025090704201759000_28.2.112.7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/14712598.2016.1213810","article-title":"Use of natalizumab in multiple sclerosis: current perspectives","volume":"16","author":"Gandhi","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"2025090704201759000_28.2.112.8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/imt-2016-0113","article-title":"Natalizumab treatment of multiple sclerosis: new insights","volume":"9","author":"Delbue","year":"2017","journal-title":"Immunotherapy"},{"key":"2025090704201759000_28.2.112.9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/NDT.S114636","article-title":"The use of natalizumab for multiple sclerosis","volume":"13","author":"Brandstadter","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2025090704201759000_28.2.112.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"2025090704201759000_28.2.112.11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/14740338.2017.1346082","article-title":"Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis","volume":"16","author":"Clerico","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"2025090704201759000_28.2.112.12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1756285617716002","article-title":"The role of natalizumab in the treatment of multiple sclerosis: benefits and risks","volume":"10","author":"Singer","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"key":"2025090704201759000_28.2.112.13","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12840"},{"key":"2025090704201759000_28.2.112.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174858","article-title":"Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?","volume":"12","author":"Kr\u00e4mer","year":"2017","journal-title":"PLoS One"},{"key":"2025090704201759000_28.2.112.15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000195","article-title":"Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values","volume":"3","author":"Schwab","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2019-002048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:20:23Z","timestamp":1757244023000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2019-002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,19]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/ejhpharm-2019-002048"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2019-002048","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]}}}